Pfizer profits up 10 per cent

the value of overseas sales, and for new products obtained in Pfizer's recent purchase of specialty firm King Pharmaceuticals. Many investors fear Pfizer, which has bought three of the largest US pharma firms over the past decade, will be far too big to...